FCMA
CLVS

Foresight Capital Management Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Foresight Capital Management Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-248
Closed -$1K – 159
2022
Q1 		$1K Hold
248
– – ﹤0.01% 142
2021
Q4 		$1K Buy
+248
New +$1K ﹤0.01% 136